EU MDR Trilogue Agreement

This agreement includes a number of clarifications to the EU Medical Device Regulations.  The Environment, Public Health and Food Safety (ENVI) Committee of the European Parliament and Council’s Committee of Permanent Representatives (COREPER) voted to endorse the trilogue agreement on June 15.  The text of the draft MDR is at the link provided.  The text still needs to have legal editing and translation before it will be published in the Official Journal.  This is expected around the end of the year and there will be a three year transition so it will be enforced around the beginning of 2020.  A couple of things specific to software in the MDR:

  1. “It is necessary to clarify that software in its own right, when specifically intended by the manufacturer to be used for one or more of the medical purposes set out in the definition of a medical device, is qualified as a medical device, while software for general purposes, even when used in a healthcare setting, or software intended for life-style and well-being application is not a medical device. The qualification of software, either as device or accessory, is independent of its location or type of interconnection between the software and a device.”
  2. One of the risks that must be removed or reduced is “the risks associated with the possible negative interaction between software and the IT environment within which it operates and interacts” (Annex I Clause 11.2)
    • In the specific requirement for software in Annex I Clause 14.2 the phrase including information security has been added to the list that software must consider and use state of the art principles.
    • Software intended to be used with mobile platforms needs to consider specific features of mobile devices.
    • A new requirement was added “The manufacturer shall describe minimum requirements on hardware, IT networks characteristics and IT security measures, including protection against unauthorized access, necessary to run the software as intended.”
    • Requirements for software placement for software.
    • Classification rules for software as a medical device (Annex VII section III clause 5.2a.).  These appear to be taken from the IMDRF SaMD classification rules.

Agreement can be viewed at this link:  EU-mdr-text-06-2016

Need Your Input!

We have been researching where and when to hold our next 3-day 62304/FDA training course and we want your feedback!
1) Does the location in the US for a public course matter to you … for example, west coast (e.g., San Francisco area) vs. east coast (e.g., Boston)?
2) What locations do you prefer?
3) Would you prefer just the 3-day FDA/62034 course or to have the option of a full week 3-day course followed by cybersecurity 1-day, and a usability 1-day?
4) What other countries would you want to see our course offered publicly?
5) What are best two months of the year for the course?  What are the least favored (not workable) months?
Please respond by email to

office@softwarecpr.com by Sep 25, 2019 if possible!

Corporate Office

15148 Springview St
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN) and Italy.